http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-2017409-B2

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2846
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28
filingDate 1970-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1979-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber DE-2017409-B2
titleOfInvention Orally applicable, cytostatic agent
priorityDate 1970-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164825
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419542732
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6252
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453047453
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18323
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555131
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6253
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415966410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450198215
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439920

Total number of triples: 20.